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Abstract
Background: Breast cancer is the most frequent cancer in women in industrialized countries. Lifestyle and environmental
factors, particularly endocrine-disrupting pollutants, have been suggested to play a role in breast cancer risk. Current epidemiological
studies, although not fully consistent, suggest a positive association of breast cancer risk with exposure to several International
Agency for Research on Cancer Group 1 air-pollutant carcinogens, such as particulate matter, polychlorinated biphenyls (PCB),
dioxins, Benzo[a]pyrene (BaP), and cadmium. However, epidemiological studies remain scarce and inconsistent. It has been
proposed that the menopausal status could modify the relationship between pollutants and breast cancer and that the association
varies with hormone receptor status.
Objective: The XENAIR project will investigate the association of breast cancer risk (overall and by hormone receptor status)
with chronic exposure to selected air pollutants, including particulate matter, nitrogen dioxide (NO2), ozone (O3), BaP, dioxins,
PCB-153, and cadmium.
Methods: Our research is based on a case-control study nested within the French national E3N cohort of 5222 invasive breast
cancer cases identified during follow-up from 1990 to 2011, and 5222 matched controls. A questionnaire was sent to all participants
to collect their lifetime residential addresses and information on indoor pollution. We will assess these exposures using
complementary models of land-use regression, atmospheric dispersion, and regional chemistry-transport (CHIMERE) models,
via a Geographic Information System. Associations with breast cancer risk will be modeled using conditional logistic regression
models. We will also study the impact of exposure on DNA methylation and interactions with genetic polymorphisms. Appropriate
JMIR Res Protoc 2020 | vol. 9 | iss. 9 | e15167 | p. 1http://www.researchprotocols.org/2020/9/e15167/
(page number not for citation purposes)
Amadou et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
statistical methods, including Bayesian modeling, principal component analysis, and cluster analysis, will be used to assess the
impact of multipollutant exposure. The fraction of breast cancer cases attributable to air pollution will be estimated.
Results: The XENAIR project will contribute to current knowledge on the health effects of air pollution and identify and
understand environmental modifiable risk factors related to breast cancer risk.
Conclusions: The results will provide relevant evidence to governments and policy-makers to improve effective public health
prevention strategies on air pollution. The XENAIR dataset can be used in future efforts to study the effects of exposure to air
pollution associated with other chronic conditions.
International Registered Report Identifier (IRRID): DERR1-10.2196/15167
(JMIR Res Protoc 2020;9(9):e15167) doi: 10.2196/15167
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Introduction
Background
Breast cancer is the most common cancer among women
worldwide, with an estimated 2.09 million new cancer cases
diagnosed globally in 2018 [1]. Over the past 30 years, its
incidence has continuously increased in France [1,2]. The rapid
increase in the worldwide incidence of breast cancer has been
associated with mass screening, menopausal hormonal therapy,
and societal changes impacting individuals’ lifestyles.
Epidemiological studies have suggested an important role of
lifestyle and environmental factors, supported by geographical
variations of breast cancer incidence and time trends in incidence
rates among migrant populations [3-5]. However, a considerable
proportion of the risk remains unexplained, and the impact of
environmental factors in the etiology of breast cancer has not
been fully explored. Epidemiology and laboratory findings
suggest that exposure to environmental pollutants, particularly
those with estrogenic potential, may influence the development
of breast cancer [6,7].
Ambient air pollution is a major public health concern related
to a range of adverse health effects, including cancer, and
accounting for an estimated 4.2 million deaths per year [8]. In
2013, the International Agency for Research on Cancer (IARC)
classified outdoor air pollution as a whole and particulate matter
as carcinogenic in humans, principally based on studies of lung
and bladder cancers [9]. However, studies on breast cancer are
scarce, and results remain inconsistent [10]. A recent
meta-analysis of individual data from 15 European cohorts
revealed no association between postmenopausal breast cancer
and exposure to various classes of particulate matter (PM2.5,
PM10, and PM coarse); however, they reported a statistically
significant positive relationship per 20 µg/m3 increase in
nitrogen dioxide (NO2) exposure [11]. Epidemiological evidence
suggests an association between breast cancer and NO2 from
traffic-related air pollution [12-15]. Furthermore, women with
extremely dense mammography density, a well-established risk
factor for breast cancer, were less likely to have higher levels
of ozone (O3) exposure [16]. Breast cancer has also been linked
to exposure to endocrine-disrupting pollutants, such as
polychlorinated biphenyls (PCBs) [17,18], dioxins [19-21],
benzo[a]pyrene (BaP) [12,22], and cadmium [23,24] with
sometimes diverging results. Furthermore, studies have reported
positive associations between traffic-related BaP exposure as a
surrogate for Polycyclic aromatic hydrocarbon (PAH) exposure
and breast cancer [25,26]. Cadmium has been classified by
IARC as carcinogenic to humans (Group 1), with sufficient
evidence for lung cancer [27]. The only study performed on
airborne cadmium exposure and breast cancer risk found no
evidence of overall increased risk; however, elevated risks for
hormone receptor-negative tumors (estrogen receptor and
progesterone receptor-negative (ER-PR–)) were observed with
higher exposure to cadmium [28].
Indoor pollution is also an important challenge for global health.
Around 3 billion people use traditional biomass fuels for
household cooking and heating [29], which is a major source
of indoor air pollution and exposure to dioxins, PAH, particulate
matter, O3, and NO2 [30-35]. However, only two studies have
investigated the impact of indoor pollution on breast cancer risk
[36,37]. Overall, current epidemiological evidence regarding
the impact of exposure to ambient air pollution and indoor
pollution on breast cancer risk is not fully consistent. In addition,
the effects of simultaneous or sequential exposures to multiple
compounds have been insufficiently explored, and the evidence
supporting the differential effects of menopausal status on breast
cancer risk and receptor status is also limited [23]. Breast cancer
is no longer considered a homogeneous disease but is a
heterogeneous disease composed of several distinct molecular
subtypes according to hormone receptor status (ER, PR, and
human epidermal growth factor receptor 2, or HER2) [38].
These subtypes each have different prognoses and can affect
women differently. Molecular pathological epidemiology, which
integrates molecular pathology into epidemiological studies has
emerged in order to test for a difference between the association
of a specific environmental exposure with subtypes classified
by molecular features in determining disease incidence/mortality
[39,40].
One of the major limitations of previous studies is the lack of
past residential history and/or historical ambient air pollution
exposure estimates, which may have resulted in exposure
misclassification, contributing to imprecise risk estimates and
bias towards the null [41]. Many epidemiological studies have
relied on a variety of exposure assessment techniques such as
JMIR Res Protoc 2020 | vol. 9 | iss. 9 | e15167 | p. 2http://www.researchprotocols.org/2020/9/e15167/
(page number not for citation purposes)
Amadou et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
using data from centrally located ambient air quality monitoring
networks, surrogates for exposures. However, such methods
are often insufficient for capturing the spatial variability of
pollutant concentrations at the local scale, both at the intra-urban
scale, and the suburban and rural scale [42]. More complex
techniques have been used in recent studies to adequately
represent the spatial-temporal variation of pollutants, including
land-use regression models, dispersion modeling, chemistry
transport models, and hybrid models [43]. These complex
methods can be combined to assess exposure to each pollutant
at a fine spatial scale and over a large area between 1990 and
2011.
Life-Course Trajectories
Exposures occurring early in life and/or during biological
windows of greater sensitivity (ie, in utero and during childhood)
have been suggested to be more strongly associated with breast
cancer risk [44,45]. However, very few studies have investigated
these effects, and the majority of research has been based on
adulthood exposures within short observation periods. These
studies may have missed critical windows or the cumulative
effects of lifetime exposure that could impact breast cancer risk
[45,46]. A lack of historical measures makes retrospective
exposure reconstruction difficult, especially for earlier periods.
Higher breast cancer incidence is commonly observed in large
cities compared with rural areas [47]. Also, women born in an
urban area are at a greater risk of breast cancer versus women
born in rural areas [47]. To our knowledge, no study has
investigated the effects of life-course residential trajectories on
breast cancer. Residence in an urban area has been suggested
to be a surrogate of air pollution exposure released from road
traffic, industrial facilities, and waste incineration [48], and to
be useful to investigate earlier periods where historical air
pollution records are unavailable and back-extrapolation
unfeasible [47].
Cumulative and Multiple Exposures
Early evidence suggests that cancer risk may not be a linear
function of cumulative carcinogen dose [49]. Individuals are
exposed simultaneously to a complex and changing mixture of
environmental exposures [50]. These may independently,
cumulatively, or interactively influence the risk of developing
breast cancer. Furthermore, in single pollutant models, it is
unclear whether an observed association is due to the effect of
the evaluated pollutant or whether it acts as a surrogate for
another pollutant from the same source. Multipollutant
approaches need to address the complex structure of mixtures
that frequently present multicollinearity. However, such
epidemiological studies are limited [51,52].
Gene × Environment Interactions
Current evidence on the role of genetic susceptibility
(polymorphisms) related to exposure to ambient air pollution
remains limited. Previous epidemiological studies have reported
interactions between genetic polymorphisms and some pollutants
[53,54]. Saintot et al reported that women carrying the Val
CYP1B1 allele and who had lived near a waste incinerator for
more than 10 years had a greater risk of breast cancer than those
with the Leu/Leu genotype and had never been exposed [55].
A positive association was found in postmenopausal women
with a CYP1A1 variant genotype [56].
DNA Methylation
Methylation is one of several epigenetic events involved in the
regulation of gene expression, and it can undergo alterations as
a consequence of environmental stimuli. Emerging evidence
suggests that exposure to ambient air pollutions could influence
DNA methylation, producing hypomethylation of repetitive
elements in leukocytes and buccal cells, as well as altered
methylation at the CpG level in specific genes [57-60]. The
biological effects of DNA methylation induced by exposure to
air pollution have been investigated in the context of lung cancer
risk [61], but little is known about their impact on breast cancer
risk.
Objectives
The overall objective of the XENAIR project is to investigate
the chronic long-term effects of exposure to multiple ambient
air pollutants and risk of breast cancer in a nested case-control
study within the ongoing French prospective E3N (Etude
Epidémiologique auprès des femmes de la Mutuelle Générale
de l’Education Nationale) cohort. More specifically, the project
aims to assess the associations between chronic exposure to
selected ambient air pollutants (particulate matter, NO2, O3,
BaP, dioxins, PCB 153, and cadmium) estimated from individual
residential addresses of study subjects from recruitment (1990)
and breast cancer risk. The study will (1) analyze exposure
trajectory profiles of individual compounds over time and
estimate breast cancer risk associated with each of these
exposure profiles; (2) estimate breast cancer risk associated
with the weighted cumulative duration of urban residence since
birth (used as a surrogate for exposure to ambient air pollutions),
as well as indoor exposure from domestic heating and
combustion activities; (3) explore approaches to estimate
multi-pollutant exposure.
The XENAIR project will further assess potential interactions
between long-term exposure to low doses of air pollutants and
genetic polymorphisms involved in air pollutant metabolism,
to address the hypothesis that breast cancer risk associated with
pollutants may depend on individual genetic susceptibility. We
will also explore the potential role of DNA methylation as a
marker of exposure to ambient air pollutions and as a potential
mediator of the effect of ambient air pollutions on breast cancer
risk. Additionally, we will estimate the fraction of breast cancers
attributable to air pollution in France based on the risk estimates
and additional costs of breast cancer management attributable
to air pollutants.
Methods
The French E3N Cohort Study
E3N is an ongoing prospective cohort study launched in 1990
to investigate the main risk factors for cancer and severe chronic
conditions in women [62]. Participants were recruited between
June 1990 and November 1991 among women aged 40-65 years,
living in France and insured with the MGEN, a national health
insurance plan covering people working with the French
education system and their families, and have been biennially
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followed-up with self-administered mailed questionnaires. E3N
is the French part of the European Prospective Investigation on
Cancer (EPIC), a vast European study coordinated by IARC
and involving nearly 500,000 Europeans in 10 countries [63].
At recruitment, 98,995 E3N participants filled in a
self-administered questionnaire, which included data about
lifestyle and reproductive factors, anthropometry, past medical
history, and familial history of cancer. To date, twelve
questionnaires have been sent to the participants (participation
rate at each questionnaire ~80%). Between 1994 and 1998,
participants were invited to give a blood specimen. Blood
samples were collected from 25,000 women, and saliva samples
were later collected from an additional 47,000 women. The
occurrence of cancer was self-reported in each questionnaire,
and a small number of cancers were further identified from the
insurance files or information on causes of death obtained from
the National Service on Causes of Deaths. Pathology reports
confirming diagnoses of invasive breast cancer (the primary
outcome of the present project) were obtained for 93% of
self-declared cases, and the proportion of false-positive
self-reports was low (<5%). Addresses were recorded at baseline
(1990) and the 5- and 9-year follow-up questionnaires (years
1997, 2000, 2002, 2005, 2008, and 2011). Postal codes were
recorded at 3- and 4-years follow-up (1993 and 1994).
Participants’ place of birth (postal code and municipality) was
obtained from the first questionnaire and assigned an urban/rural
status based on data from the closest national census [64].
Informed consent was obtained from each participant, and the
study was approved by the French National Commission for
Data Protection and Privacy (CNIL).
Covariate Assessment
Data on established and potential breast cancer risk factors were
available from the self-administered questionnaires at baseline.
Regular updates have been collected on smoking, anthropometry
(height, weight), physical activity, diabetes, hypertension, benign
breast disease, gynecological screening, family history of breast
cancer (FHbreast cancer), education, and reproductive factors.
Women completed two validated self-administered diet history
questionnaires (DHQ) in 1993 and 2005. The E3N DHQ covered
the daily consumption of 208 food items by collecting food
frequencies and portion sizes for eight meals and snacks during
the day [65,66]. Dietary exposure to BaP, dioxins, PCB 153,
and cadmium will be assessed for each woman by combining
consumption data from the E3N DHQ and food contamination
data available for France. Contamination data for BaP, dioxins,
PCB 153, cadmium are available from the French agency for
food safety (ANSES) [67,68].
Study Population
The present study is based on a nested case-control subset of
the E3N cohort. It involves 5222 histologically confirmed
incident breast cancer cases identified during the 1990-2011
follow-up period. Women were included if they had completed
their home address at baseline, lived in the French metropolitan
territory during the 1990-2011 follow-up time, and not had any
cancer at baseline. For each breast cancer case, one control was
randomly selected by incidence density sampling, among cohort
participants at risk of breast cancer at the time when the case
was diagnosed, using the follow-up time since inclusion into
the cohort as the time axis. In order to best select appropriate
controls according to the planned studies, two complementary
groups of cases were set, according to the presence of a blood
sample, saliva sample, or no biological sample available. For
the first group of cases (with a blood sample), controls were
matched to cases on the department of residence, age (±1 year),
date (±3 months), and menopausal status at blood collection.
Controls for the second group (without a blood sample) were
matched on the same criteria but collected at baseline, and
additionally matched on the existence or not of a saliva sample.
Additional Data Collection: Residential History
Questionnaire Collection and Assessment of Indoor
Air Pollution
A structured questionnaire was sent to all selected cases and
controls to collect lifetime residential addresses from date of
birth to the present (street address, municipality/city, postal
code), school and workplace addresses, commute duration (
“less than 30 min,” “between 30 and 60 min,” “more than 60
min”) and type (“walking,” “cycling,” “motorcycle riding,”
“driving a diesel car,” “driving a gasoline car,” or “using public
transportation”), and information on domestic heating and
combustion activities. We also collected information on the age
when starting and stopping living in each reported home.
Women were asked to report the period during which their home
was built (before 1948, between 1948 and 1974, or after 1974),
and whether it overlooked a courtyard or a street (courtyard,
street, or both). In terms of indoor heating, they reported their
main type of heating (collective central, or individual) and their
main source of heating (wood, charcoal, electricity, gas, or fuel).
Regarding indoor wood-burning stove or fireplace cooking,
women were asked whether they used an indoor wood-burning
stove or a fireplace in their home (yes, no), and if yes, the type
(stove/wood stove, open fireplace, or closed fireplace).
Information on the use and frequency of cooking foods on the
barbecue was also collected (never, rarely (once to twice per
year)), occasionally, or frequently (at least once a month)).
Study participants additionally answered questions on whether
they burned green waste (yes, no), and if yes the frequency
(never, rarely (once or twice a year, occasionally, or frequently
(at least once a month)), and the quantity of green waste burned
every year (less than 1 m3, 1-5 m3, or more than 5 m3). The
overall response rate was 65.4%.
Geocoding of Residential History and Industrial
Sources
The methods of geocoding residential history and industrial
sources have been described in detail elsewhere [69]. Briefly,
residential histories from the E3N follow-up questionnaires and
the residential questionnaire will be geocoded (X and Y
coordinates, addresses) using ArcGIS Software (ArcGIS Locator
version 10.0, Environmental System Research Institute) and
the national addresses database from the National Geographic
Institute (BD Adresse, IGN). Geocoding will be performed by
a trained technician blinded to the case-control status of the
participants.
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Assessment at the national level of exposure to selected
pollutants (PM10, PM2.5, NO2, O3, BaP, dioxins, PCB 153, and
cadmium) will be based on complementary models according
to data availability and pollutant emissions characteristics (Table
1). Specifically, we will use a regional chemistry-transport
model (CHIMERE) [70], an urban gaussian dispersion model
(SIRANE) [71], a land-use regression model [72] and a
GIS-based metric [73]. A detailed description of these models
is provided in Multimedia Appendix 1.
Table 1. Summary of the models used to assess atmospheric exposure.
PollutantsOutput/GoalAreaYearsSpatial and temporal res-
olution
Type of model (name)
NO2, PM2.5/10, O3, cadmi-
um, dioxins, PCB 153, BaP
Concentration/Exposure
assessment




National (France)2010-201250 × 50 m, annuallyNational LURa model
NO2, PM2.5/10, O3Concentration/Exposure
assessment


























bGIS: geographic information system.
PM10, PM2.5, NO2, and O3
We will use land-use regression models to estimate PM10, PM2.5,
NO2, and O3 concentrations at the local scale (50 × 50 m) and
develop “hybrid” models combining outputs from CHIMERE
(concentrations over the whole French territory from 1990 to
2011, with a spatial resolution of 0.125° × 0.0625°) and
localized variables describing road traffic and land use,
nationwide. A so-called “baseline land-use regression model”
will be constructed based on average measurement of 2010-2012
to ensure that meteorological conditions in a particular year do
not bias predictions for other years. In this manner, we will also
benefit from the largest quantity and the best quality of
measurement data. This model will be validated against
measurement across France by performing a hold-out validation
(ie, independent monitoring sites). Once established, this model
will be back-extrapolated until 1990. However, this step will
benefit from the CHIMERE modeling results that will provide
local concentrations from 2011 to 1990 to help adjust the
back-extrapolation.
Dioxins and Cadmium
Ambient air concentration measurements of dioxins and
cadmium are extremely fragmented and, therefore, it is difficult
to estimate exposures. In addition, these measurements are
unevenly distributed over time and space with an increasing
number of measurements from the 2000s onwards, while at the
same time, emissions are falling sharply, precluding the use of
land-use regression models. Since dioxins and cadmium
emissions over the period were mainly due to industrial sources
and given the size of the study area, the use of dispersion models
over the entire territory would not provide a sufficient spatial
and temporal resolution to characterize exposure. To estimate
dioxins and cadmium exposure at any point in the national
territory over the 1990-2011 period, we adopt instead the
approach used in a previous epidemiological study, ie, a
GIS-based metric [74]. The latter was validated by comparison
with a dispersion model in multiple contexts and is based on a
detailed emission inventory [73].
BaP and PCB 153
Unlike dioxin and cadmium, no detailed emission inventory is
currently available at a local scale for BaP and PCB 153. As a
result, background concentrations from CHIMERE will be
directly used as the reference concentrations for these
compounds. BaP concentrations were already simulated with
CHIMERE by Guerreiro et al [75], whereas PCB-153, cadmium,
and dioxins are added into the model.
Sensitivity Analysis of Concentration Modeling
A sensitivity analysis will be done to compare the ability of
different models to classify subjects correctly according to their
exposures. The performance of the models will be compared to
each other and with measurement data in ambient air. One of
the most important objectives will be to quantify
misclassification created by using a national model to assess
exposures (see Multimedia Appendix 1).
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Statistical Methods and Power Calculation
Associations with breast cancer risk will be modeled using
conditional logistic regression models, considering different
concentrations for each compound, and fuel sources for indoor
heating and cooking. Exposure variables will be investigated
as continuous and categorical variables, and models will be
conditioned on the matching factors. All analyses will be
adjusted for potential confounding and known breast cancer
risk factors available from the self-administered questionnaires.
Simple imputation methods will be used for missing continuous
data, and a category of missing data will be created for
categorical covariates.
Potential effect modification by follow-up time, age, BMI,
tobacco smoking status, alcohol consumption, reproductive
factors, and birthplace status will be tested using tests for
interaction (likelihood ratio test). Further subgroup analyses
will be conducted according to tumor hormone receptor status
(ER and PR) and menopausal status. Heterogeneity of
associations across hormone receptor subgroups will be assessed
using polytomous logistic regression models [76].
The potential non-linearity of the relationship between exposures
and breast cancer risk will be examined using restricted cubic
splines [77] or fractional polynomials. In order to reduce residual
confounding, potential non-linearity of the effects of continuous
confounders will be accounted for using the same approach
[78,79].
B-spline functions will be used in logistic regression models to
estimate (1) the relative weight of the exposure dose versus time
since recruitment or age at exposure and (2) breast cancer risk
associated with the weighted cumulative duration of urban
residence since birth (a surrogate for urban air pollutant
exposure) [80,81].
To identify exposure trajectory profiles of individual compounds
over time since recruitment in the cohort E3N, and to estimate
breast cancer risk associated with each of these exposure
profiles, we will use joint latent class mixed models [82].
Finally, different approaches will be explored in order to assess
multipollutant exposure (Bayesian modeling, principal
component analysis) [51,83].
For sensitivity analyses, models will be adjusted for estimated
dietary exposure to each pollutant, considering the diet as a
route of exposure separate from inhalation.
Table 2 presents different scenarios considered to calculate the
statistical power to detect an association between a binary
exposure (high versus low level) and the risk of breast cancer,
using the power analysis method for matched case-control
studies and a 5% type I error [84]. Overall, even for a low
exposure prevalence of 20% and a case-control correlation of
0.2, we will have 97% power to detect an odds ratio of 1.2, and
100% power to detect an odds ratio of 1.5.
Table 2. Statistical power and sample size calculation.
PowerOdds ratio adjusted for the
matching variables
Correlation of exposure between
matched controls and cases









Gene × Environment Interaction and DNA Methylation
Analyses
To explore gene × environment interactions, we will first use
a case-only study design, similar to Saintot et al [55], to analyze
the interaction of exposure with single nucleotide
polymorphisms in the metabolic pathways of dioxins, PCBs,
and PAHs (cytochrome P450, glutathione S-transferase, and
related pathways), growth factor, and inflammation pathway
genes, in 2500 cases from a previous breast cancer study. A
second analysis will be done in a nested case-control subset of
2500 cases and 2500 matched controls. DNA methylation
analyses will be based on at least 400 case-control pairs with
controls matched for age at recruitment, age at diagnosis of the
corresponding case, and type of biospecimen (blood or saliva).
These methods have been described in Multimedia Appendix
1.
Attributable Fraction and Cost Analyses
The Levin formula will be used to estimate the attributable
fraction in the French general population, using our ORs
estimates and nationwide exposure estimates [85]. Adopting
the French national insurance perspective, direct costs (ie, those
associated with diagnosis, surgery, chemotherapy, radiotherapy,
and/or hormone therapy, and follow-up +/- relapse) of breast
cancer attributable to ambient air pollution exposure will be
assessed based on systematic reviews, observational and
modeling studies, and expert opinion [86,87]. Costs will be
combined with estimated attributable fractions to assess breast
cancer treatment costs attributable to air pollutants in France.
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Ethics Approval and Consent to Participate
Our research is based on the E3N French national cohort.
Informed consent was obtained from all participants, and the
study was approved by the French National Commission for
Data Protection and Privacy (CNIL).
Results
The study is still ongoing. XENAIR will provide relevant and
innovative evidence to fill gaps regarding the complex
association of breast cancer risk with long-term exposure to
multiple air pollutants (PM2.5, PM10, NO2, O3, dioxins, PCB
153, cadmium, and BaP) from 1990 to 2011, using
complementary models (land-use regression and atmospheric
dispersion models) at a fine spatio-temporal resolution. Our
research will contribute to improving our understanding of
life-long exposure and exposure at different life stages to urban
settings. In addition, the investigation of gene × environment
interactions will allow the identification of groups of women
with genetic susceptibility to environmental carcinogens, and
thus improve our understanding of the interaction of individual
susceptibilities with environmental exposure. Furthermore, the
identification of methylation markers of exposure to
environmental pollutants will contribute to extend our
understanding of breast cancer etiology and reveal biomarkers
of exposure.
Discussion
This study is prompted by the increasing incidence of breast
cancer, although leveling off in recent years, persistent air
pollution levels worldwide, and suggestive evidence for an
association of breast cancer risk with several ambient air
pollutants. To our knowledge, the XENAIR project is one of
the largest prospective studies to investigate exposure to ambient
air pollution and breast cancer risk, and it should significantly
increase current knowledge on the health effects of air pollution.
Investigating the impact of environmental exposure on breast
cancer risk requires large studies with well-defined exposure
information, as well as individuals’ risk factors and potential
confounders.
Our research is based on the existing French national cohort,
E3N [62]. This prospective cohort study is particularly well
documented, with updated information every 2 years on
established breast cancer risk factors and past medical history.
The availability of detailed information on lifestyle factors,
family history of breast cancer, and reproductive factors will
allow for better control of confounding factors and further
investigation of potential effect modifiers. Also, further
Molecular pathological epidemiology analyses will be conducted
according to hormone receptor status (ER and PR) of breast
cancer. Detailed classification of tumor subtypes and their
analyses will allow phenotype refinement, improve the
identification of specific air pollution risk factors, and
characterize the pathogenic molecular mechanisms of breast
cancer. The Molecular pathological epidemiology research
paradigm provides novel insights into interactions among
environment, tumor, and host but also provides an exemplary
model of integrative scientific approaches and contributes to
advancements in precision medicine, therapy, and prevention
[40].
Furthermore, because women from the E3N cohort are mostly
teachers or have affiliated occupations, with potentially
negligible occupational exposure, bias related to occupational
exposures to the selected pollutants will be avoided. Since
exposure to dioxins, cadmium, PCB 153, and BaP in the general
population occurs through the ingestion of contaminated food
and inhalation, the availability of consumption data from the
E3N dietary questionnaires available for these compounds will
allow further adjustment for dietary exposure [88]. Inhalation
is the only route of exposure to PM10, PM2.5, NO2, and O3 in
humans that is relevant to health effects; accordingly, we do
not expect confounding from dietary exposure to play a role in
exposure to these pollutants. The XENAIR project will also
benefit from the large dioxin and cadmium sources inventories
(1990-2011) [43,89] as well as the previously developed
GIS-based metric [73]. By evaluating the transferability of the
ESCAPE land-use regression models [90] to predict air pollution
concentrations in large areas in France, XENAIR will contribute
to the development of these technological advances for the
assessment of long term exposure to air pollutants. One of the
major strengths of our study is, however, the combination of
CHIMERE and measurements to do back-extrapolation rather
than measurements alone.
The use of GIS-based methods, combined with national-scale
land-use regression and air dispersion models at different spatial
and temporal resolutions, will help to better describe
environmental pollutant exposure better. The large dataset
created by thorough geocoding of subjects’ residential history
[69] will enable integrative analyses of additional environmental
risk factors. Findings from our research will create a basis for
refined assessments of the impact of exposure to air pollution
on other diseases within the E3N cohort or other national cohort
studies.
Limitations of the XENAIR project include the lack of available
historical exposure data before 1990, making it impossible to
have a complete individual lifetime dose estimate for the E3N
women; however, investigating lifetime urban/rural status will
partially remediate this limitation. The spatial resolution of the
PCB153 and BaP model will be limited to 7 km2, which may
not be sufficient to describe airborne exposure in dense urban
contexts. From a more global perspective, the assessment of
historical airborne pollutant exposure will create more
uncertainties that must be taken into account. We may minimize
the impact of these biases by using different approaches to
exposure assessment.
In conclusion, XENAIR will create a large-scale, national
dataset on multiple ambient air pollutant exposures and
contribute to a better understanding of environmental modifiable
risk factors related to breast cancer. The results of our
interdisciplinary research will contribute to the concept of the
exposome [50] at the individual and societal levels, and provide
support to governments and policy-makers to better design
effective public health prevention strategies and to promote
urban policies in order to reduce exposure to ambient air
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pollution further. The XENAIR dataset will enable future
investigations of the effects of exposure to air pollution
associated with other diseases.
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